Qiagen NV (Qiagen NV) Days Sales Outstanding : 63.49 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Days Sales Outstanding?

Qiagen NV's average Accounts Receivable for the three months ended in Dec. 2023 was $354 Mil. Qiagen NV's Revenue for the three months ended in Dec. 2023 was $509 Mil. Hence, Qiagen NV's Days Sales Outstanding for the three months ended in Dec. 2023 was 63.49.

The historical rank and industry rank for Qiagen NV's Days Sales Outstanding or its related term are showing as below:

QGEN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.45 Med: 75.01 Max: 88.08
Current: 61.74

During the past 13 years, Qiagen NV's highest Days Sales Outstanding was 88.08. The lowest was 58.45. And the median was 75.01.

QGEN's Days Sales Outstanding is ranked better than
62.67% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs QGEN: 61.74

Qiagen NV's Days Sales Outstanding increased from Dec. 2022 (58.15) to Dec. 2023 (63.49).

Qiagen NV Days Sales Outstanding Historical Data

The historical data trend for Qiagen NV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Days Sales Outstanding Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

88.08

74.71

60.19

58.45

65.52

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															58.15	60.25	58.07	61.29	63.49

Competitive Comparison of Qiagen NV's Days Sales Outstanding

For the Diagnostics & Research subindustry, Qiagen NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Days Sales Outstanding falls into.

Qiagen NV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Qiagen NV's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (323.75	+	381.877)	/	2 )	/	1965.311	*	365
=	352.8135					/	1965.311	*	365
=	65.52

Qiagen NV's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (326.69	+	381.877)	/	2 )	/	509.162	*	365 / 4
=	354.2835					/	509.162	*	365 / 4
=	63.49

Qiagen NV (NYSE:QGEN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Qiagen NV Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives